Immune Thrombocytopenia (ITP) Market is Estimated to Record Promising CAGR of 5.78% During Forecast 2018-2023

Market Highlights:
As per the latest report published by Market Research Future (MRFR), the Global Immune Thrombocytopenia (ITP) is set to surpass a valuation of USD 2,300 Mn by the year 2023, reflecting a healthy CAGR. ITP is a blood related disorder that cause abnormal clotting. Some of the discomforts caused by the disease include bruising, bleeding and severe drop in platelets counts. Both minors and adults can develop the condition. The disease is classified into primary and secondary form. Primary form of ITP occurs on its own while the latter is an offshoot of another condition. The condition can be triggered by reactive medications, autoimmune disease, pregnancy and certain type of cancers.
ITP is among the most commonly occurring disorder across the globe. In addition, the incidence rate has continued to spiral upwards in recent years. Factors as such as are fueling the demand for drugs and therapeutics for ITP. Currently, there are four treatment options available for ITP - intravenous   immune   globulin (IVIG), thrombopoietin receptor agonists, corticosteroids and immune-suppressing drugs. Though these treatment options have gained a healthy mileage, they come with certain degree of risk of side-effects. Nonetheless, increased focus towards innovation and R&D is likely to create new avenues for market players in the foreseeable future. 
Competition Tracking:
·         Dova Pharmaceuticals
·         Jiangsu Hengrui Pharmaceutical Co
·         Ligand Pharmaceuticals
·         Rigel Pharmaceuticals
·         Kyowa Hakko Kirin Co
·         Amgen Inc
·         Shire
·         F.Hoffmann-La Roche Ltd
·         Shionogi Inc. CSL Limited
·         Novartis

Browse Complete Report Details and TOC Exclusively  @ https://www.marketresearchfuture.com/reports/immune-thrombocytopenia-itp-market-6996
Segmental Analysis:
·         The report includes a thorough segmental analysis of the market on the basis of end-user, treatment, and type.
·         By end-user, the market has been segmented into specialty centers, hospitals and clinics, research and academic institutes and others. Currently, the hospitals & clinic segment accounts for more than one-third share of the market. During the forecast period, the segment is expected to record an impressive 6.22% CAGR.
·         By treatment, the market has been segmented into thrombopoietin receptor agonists, corticosteroids, intravenous immunoglobulins and others. In terms of value, the corticosteroids segment currently commands for close to 40% market share and is projected to surge at a CAGR of 5.57%.
·         Based on type, the market has been segmented into acute immune thrombocytopenia and chronic immune thrombocytopenia. The chronic immune thrombocytopenia segment currently accounts for over two-third market and is expected to highly profitable in 2018 and beyond. The segment is likely to reach a valuation of USD 2,036.9 Mn by the end of assessment period, exhibiting a CAGR of 5.94%. Approval of numerous targeted treatments coupled with the rising prevalence of ITP is proving the impetus on the segment’s growth.
Regional Analysis:
The market has been covered across regions such as Europe, Americas, the Middle East & Africa (MEA) and Asia Pacific (APAC). In 2017, the Americas segment accounted for the largest market share and trend is likely to continue beyond 2018. Some of the factors that are supporting the growth of the market in the region include rising prevalence of ITP in countries such as the US, Canada, Mexico and Brazil, high healthcare expenditure and favorable reimbursement policies. As per the National Organization of Rare Disorders (NORD), the incidence rate of Immune thrombocytopenia among Americans is 3.3 per 100,000 adults/year approx. Meanwhile, Europe and APAC currently hold the second and third spot respectively. Presence of advanced healthcare infrastructure and strong government support is supporting the growth of the market Europe. In Asia Pacific, the market has gained a healthy momentum in recent years owing to factors such as increase penetration of healthcare services, growing awareness and expanding patient pool. The market for ITP in APAC is expected to witness a strong growth over the next couple of years.
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com

Comments

Post a Comment

Popular posts from this blog

Proteomics Market Analysis, Demand Overview, Growth Analysis, Current Trends, Updates, and Global Industry Forecast to 2023

Market Highlights: The global proteomics market is anticipated to hold a market value of USD 23.2 billion in the year 2017 and is expected to grow at a CAGR of 14.1% during the forecast period. Proteomics is a science which is used to estimate the rate of protein production, interaction of proteins with one another, involvement of proteins in metabolic pathways, and modification of proteins. Also, it has extensive applications in drug discovery, development of personalized medicines, and identification of markers for disease diagnosis. Increasing need for personalized medicine, R&D expenditure, technological advancements and increased funding for proteomics project are expected to drive the market growth over the forecast period. For instance, in July 2017, Biognosys AG received USD 5 million funding from its new as well as existing investors. These new funds will be used for extending commercial operations and also to accelerate the development of next generation prote
Read more

Surgical Drapes and Gowns Market is Growing Dynamically at a Speedy CAGR of 4.4% During Forecast 2018-2023

Market Overview: Market Research Future Reports have accumulated study insights and states that the global surgical drapes and gowns market size is expected to expand significantly by the year 2023 as it already held a valuation of USD 2.23 billion in 2017. Now that with the current scenario, it has been observed that the surgical drapes and gowns market is set to proliferate at a CAGR of 4.4% over the forecast period. Surgical Drapes and Gowns Market Share   Held Valuation Up to USD 2.23 Billion in 2017 and Expected to Proliferate in Coming Years Says Global Top Manufacturers A gown and drape have found its immense importance with its usage in the surgical world. These gowns and drapes are useful in reducing the risk of disease. These are supplied by healthcare professionals for minimizing the exposure of transfer of infection while maintaining sterility of spaces. Since its optimum usage in hospitals and clinics globally, it is gaining significant traction in recent time.
Read more

Dental Lasers Market Growth Values, Advanced Share, Demand Overview and Industry Forecast to 2023

Market Overview: The global Dental Lasers Market , as per a report by Market Research Future (MRFR) is touted to register a healthy CAGR of 5.2% during the assessment period ( 2017-2023 ). Dental lasers are considered devices that emit coherent light beams, mainly suited to perform oral surgeries. These lasers prevent the need for surgical instruments like coherent light beams, coherent light beams, and handpieces. Dental lasers also offer benefits like less contamination, less trauma, and less bleeding and are being accepted across the globe due to their ability like short healing time, lower light exposure, portability, and does not require anesthesia. Competitive Dashboard: ·          Biolase ·          AMD Lasers ·          Convergent Dental ·          Cao Group ·          Fotona D.D ·          Danaher Corporation- Kavo Dental GmbH ·          Millennium Dental Technologies ·          Ivoclar Vivadent AG ·          Syneron Dental Lasers-Syneron Medical Ltd
Read more